# Topical Morphine for Analgesia in Patients With Skin Grafts

> **NCT00362219** · PHASE3 · WITHDRAWN · sponsor: **Rambam Health Care Campus**

## Conditions studied

- Skin Transplantation
- Pain

## Interventions

- **OTHER:** Placebo
- **DRUG:** Morphine - .25 mg
- **DRUG:** Morphine
- **DRUG:** Morphine

## Key facts

- **NCT ID:** NCT00362219
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01
- **Primary completion:** 2023-12
- **Final completion:** 2024-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no patients were recrueted
- **Last updated:** 2022-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00362219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00362219, "Topical Morphine for Analgesia in Patients With Skin Grafts". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00362219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*